Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SOT-102 by SOTIO Biotech for Metastatic Pancreatic Cancer: Likelihood of Approval
SOT-102 is under clinical development by SOTIO Biotech and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData,...
Data Insights
SOT-102 by SOTIO Biotech for Gastric Cancer: Likelihood of Approval
SOT-102 is under clinical development by SOTIO Biotech and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...